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ABSTRACT
Objectives: The aim of this systematic review of
randomised controlled trials (RCTs) and controlled
trials (non-RCTs, NRCTs) is to investigate the
effectiveness and related costs of case management
(CM) for patients with heart failure (HF) predominantly
based in the community in reducing unplanned
readmissions and length of stay (LOS).
Setting: CM initiated either while as an inpatient, or
on discharge from acute care hospitals, or in the
community and then continuing on in the community.
Participants: Adults with a diagnosis of HF and
resident in Organisation for Economic Co-operation
and Development countries.
Intervention: CM based on nurse coordinated
multicomponent care which is applicable to the
primary care-based health systems.
Primary and secondary outcomes: Primary
outcomes of interest were unplanned (re)admissions,
LOS and any related cost data. Secondary outcomes
were primary healthcare resources.
Results: 22 studies were included: 17 RCTs and 5
NRCTs. 17 studies described hospital-initiated CM
(n=4794) and 5 described community-initiated CM
of HF (n=3832). Hospital-initiated CM reduced
readmissions (rate ratio 0.74 (95% CI 0.60 to 0.92),
p=0.008) and LOS (mean difference −1.28 days
(95% CI −2.04 to −0.52), p=0.001) in favour of CM
compared with usual care. 9 trials described cost
data of which 6 reported no difference between CM
and usual care. There were 4 studies of community-
initiated CM versus usual care (2 RCTs and 2
NRCTs) with only the 2 NRCTs showing a reduction
in admissions.
Conclusions: Hospital-initiated CM can be
successful in reducing unplanned hospital
readmissions for HF and length of hospital stay for
people with HF. 9 trials described cost data; no
clear difference emerged between CM and usual
care. There was limited evidence for community-
initiated CM which suggested it does not reduce
admission.
INTRODUCTION
Applying current prevalence ﬁgures to popu-
lation estimates suggests that more than
550 000 individuals (more than 308 000 men
and slightly fewer than 250 000 women) in
the UK are living with heart failure (HF).1
Quality and Outcome Framework (QOF)
data supports this: in 2012/2013, just over
480 000 patients were recorded as having
HF.2 The average age of patients with HF in
general practice in the UK is 77 years.3
Prior to 1990, 60–70% of patients died
within 5 years of diagnosis, and admission to
hospital with worsening symptoms was a
regular and recurrent event.4–6 Effective
treatment has improved care, with a relative
reduction in hospitalisation in recent years
of 30–50%, and smaller but signiﬁcant
decreases in mortality.4–6
More than £6.8 billion was spent on treating
all cardiovascular disease within the National
Health Service (NHS) in England in 2012/
2013 with 63% of these costs coming from
within secondary care and 21% within primary
care. Within secondary care, non-elective
inpatient admittance for cardiovascular
disease, that is, emergency admissions, had the
greatest expenditure with £1925 million.1
Strengths and limitations of this study
▪ High-quality systematic review.
▪ Interventions examine nurse-led multicomponent
care of patients with heart failure.
▪ Focus on use of resources specific to heart
failure.
▪ Community-initiated case management trials were
limited in quantity and were mostly of low quality.
▪ Lack of cost data in most trials.
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Case management (CM) is the process of planning,
coordinating and reviewing the care of an individual. We
used the deﬁnition cited by the King’s Fund in the UK ‘A
collaborative process of assessment, planning, facilitation,
care coordination, evaluation, and advocacy for options
and services to meet an individual’s and family’s compre-
hensive health needs through communication and avail-
able resources to promote quality cost-effective
outcomes’.7 The NHS has used less-intensive approaches
than the traditional US model, for example, through the
use of nurses to support older people and those with
long-term conditions at home.8 In this review, we have
focused on CM based on nurse coordinated multicompo-
nent care of patients which is applicable to the primary
care-based health systems such as that in the UK.
A previous systematic review and meta-analysis shows
that CM is not effective in reducing unplanned hospital
admissions for the general older/elderly population.9
However, limited data suggest that CM for patients with
HF is promising.10 This current review aimed to (1)
identify the evidence of the effectiveness and related
costs of CM interventions for patients with HF predom-
inantly based in the community and (2) to better under-
stand the potential success of CM by examining the
components of tested interventions.
METHODS
Search
Databases and registries
A search strategy was developed using keywords for the
electronic databases according to their speciﬁc subject
headings or searching structure. The search strategy was
run from 1985 to 2012 in the OVID databases—
MEDLINE, Excerpta Medica Database (EMBASE),
Cumulative Index to Nursing and Allied Health Literature
(CINAHL) and PsycINFO on 2 July 2014 (see online sup-
plementary appendix 1). The search strategy was modi-
ﬁed to search internet sites such as the Agency for
Healthcare Research and Quality (AHRQ) and the King’s
Fund. A pragmatic update of these searches was con-
ducted on 20 November 2015 using the full search strat-
egy and run in MEDLINE and MEDLINE in process only.
Other sources
Once the included papers were determined, both back-
wards (reference list of paper) and forwards citation
searching (via Google Scholar) was performed to iden-
tify any other potentially relevant studies. All authors of
included studies in the ﬁeld were contacted with data
queries and to identify additional relevant studies.
Eligibility criteria
Randomised controlled trials (RCTs) and other con-
trolled studies (non-RCTs, NRCTs; controlled trials, con-
trolled before and after studies, analytic cohorts,
comparative studies) were included as determined by
our eligibility criteria. We were aware from our previous
work that not all community-based studies were rando-
mised and felt it was important to be more inclusive in
order to understand why CM may work for HF. CM
interventions needed to be initiated either while as an
inpatient or on discharge from acute care hospitals
including the emergency department (ED), or in the
community, and then continue on in the community.
Only studies including adults with HF in Organisation
for Economic Co-operation and Development (OECD)
countries were included as the outcomes were more
likely to be comparable for synthesis, and relevant to the
UK situation.11 Studies were included as long as one of
the outcomes of interest was unplanned hospital (re)
admissions, ED attendance, length of hospital stay
(LOS) as well as related costs of the interventions. Other
outcomes of interest were primary healthcare resources,
for example, general practitioner visits, visits to other
primary care health professionals or services and pre-
scriptions. Studies written in any language were consid-
ered if there was an English abstract available.
Reference management and study selection
EndNote and Excel were used to manage the references.
Duplicates were removed from the EndNote ﬁle.
References underwent a two-stage process of screening
using the inclusion and exclusion criteria by two
reviewers independently (ALH, AK, RJ). First, a screen
of titles and abstracts (if abstract available) and second
screening of the full paper was conducted. Where there
was continued disagreement between reviewers about
including or excluding a paper, a third reviewer made
the ﬁnal decision (SP or RJ).
In addition to the included quantitative intervention
papers, we identiﬁed relevant reviews from the search.
Any potentially relevant conference proceedings were
followed up, ﬁrst by searching in MEDLINE to see if the
study had been published. If the study was not pub-
lished, the authors were contacted where possible to
check if the studies were likely to be published within
the work frame of this review.
Data extraction and assessment of risk of bias
Data were extracted into a custom-designed table which
included description of trial type, participants, interven-
tion, controls, outcome measures and results. Based on
the Kings Fund deﬁnition of CM, we devised taxonomy
of intervention components8 (table 1). As part of this
data extraction process, the intervention and control
treatments were also described by their component
parts, for example, monitoring signs and symptoms
using the framework of the CM deﬁnition.
Quantitative data concerning the outcomes of interest
were extracted into the Cochrane Revman software. The
Cochrane risk of bias tool was used to record trial bias
for RCTs and the Effective Practice and Organisation of
Care (EPOC) risk of bias tool was used for NRCTs.12
These processes were performed by one author and
checked by a second (ALH, AK). Any disagreements
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Table 1 Components of CM interventions
Definition and total prevalence of components of CM interventions
Number of hospital-initiated
CM vs usual care with
component present
(total studies=16)
Number of community-initiated
CM vs usual care with component
present (total studies=4)
Assessment/evaluation
Monitoring signs and symptoms (n=18)
Encompasses general care of patients with CHF which is likely to include establishing a relationship with patient
over visits, physical and cardiac status checking, lifestyle assessment, general medication check and screening
tests, for example, depression, dementia
14 4
Medication review (n=8)
Review and adjustment of medication by experienced case manager (nurse), pharmacist, GP or consultant often
using a combination of these health professionals
6 2
Assessment of home environment (n=4)
Assessment carried out by case manager to identify any issues or potential issues with home environment, for
example, stairs
4 0
CM meetings/feedback to other HPs (n=5)
Planning
Group meetings of health professionals involved in patients with CHF care with the aim of reporting on and
planning for patients care
3 2
Appointment organisation (n=2)
Case manager checking medical appointments, ensuring ability to go, etc 2 0
Advance care planning (n=1) 1
Facilitation
Education/self-management (n=18)
Educating patients with CHF about their condition, treatment and what to expect. The aim of this is to assist
self-management (care with assistance of health professionals) and self-care (patient engaging in activities to
promote their health and well-being).
15 3
Patient-directed access (n=6)
The ability of patients with CHF to initiate care from the case manager or CM service 6 0
Care coordination
Referral to…(n=14)
When the case manager refers the patient to other health or social care professionals, this can be GP hospital
consultant, social care or tests.
11 3
Advocacy for options and services
Equipment (n=4)
Provision of items to assist patient’s healthcare such as pill counters, weighing scales and measured water bottles 3 1
Physical therapy (n=1)
Patient with CHF receiving physical therapy/rehabilitation 1 0
Support group (n=1)
CHF attending or being offered the opportunity of a support group. 1 0
Other
Family involvement (n=9)
When the case manager involves the patient’s family in terms of information, education or involvement, for example,
goal setting in patients’ care or active monitoring
8 1
Emotional support (n=1)
Case manager providing emotional support to patient with CHF. 0 1
CHF, chronic heart failure; CM,case management; GP, general practitioner; HP, health professional.
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were resolved by discussion and if necessary with a third
author (RJ, SP).
Data analysis
Trials were divided as previously described by Huntley
et al9 into hospital-initiated CM and community-initiated
CM. Where there were data from three or more studies,
effect sizes were calculated and presented in forest plots
as rate ratios ((re)admissions) or mean differences
(LOS) using Revman software. If the heterogeneity of
the combined data was >50%, a random-effects model
was used for analysis.
We conducted prespeciﬁed sensitivity analysis in
response to the risk of bias assessment of studies, remov-
ing high risk of bias studies as appropriate; the results of
both analyses are presented.13 We conducted prespeci-
ﬁed subgroup analysis to explore the effects of CM dur-
ation (3, 6 and 12 months plus) on hospital admission
and LOS. There was insufﬁcient detail in trials to
perform subanalysis by severity of HF or intensity of
intervention.
Data were assessed narratively in respect of the compo-
nents of interventions using the CM deﬁnition cited
above as guidance8 (table 1). In addition, where pos-
sible, post hoc subgroup analysis was conducted in
Revman in which interventions with components of
interest were compared with those that did not have
these components.
RESULTS
The systematic review yielded 22 studies with data pub-
lished over 32 papers of which 17 were RCTs and 5 were
NRCTs, all published in the English language14–45
(ﬁgure 1). No relevant studies were identiﬁed in a prag-
matic update using the full search strategy run in
MEDLINE and MEDLINE in process only in November
2015. Seventeen of these studies described
hospital-initiated CM (n=4794),14 15 17 18 20–24 26–28 31 32
and ﬁve described community-initiated CM of HF
(n=3832).38 42–45 The PRISMA checklist was used to
ensure the quality of our systematic review manuscript.
Figure 1 PRISMA flow diagram. CCT, controlled clinical trial; CHF, chronic heart failure; CM, case management; EOL, end of
life; RCT, randomised controlled trial.
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Profile of patients
The range of female participants in the trials was
1–58%, but the majority of trials had relatively even
gender divide (table 2). Comorbidity and multimorbidity
were common. Eight of the 22 trials gave no detail on eth-
nicity of participants; in four studies, the triallists used
white/non-white and English-speaking/non-English-
speaking categories. In the remaining 10 studies, a fuller
proﬁle was described. Twelve of the 22 trials were con-
ducted in the USA and the ethnicity proﬁle reﬂected that
including Spanish speaking/Hispanic, American Indian,
black, African-American, Asian and white participants.
The majority of trials described the severity of HF
using New York Heart Association (NYHA) classiﬁcation.
Twelve of the trials gave a breakdown of numbers or per-
centages in the I–IV classes with some trials only giving
numbers of participants for the III and IV classes. In
these trials, the percentage range of III and IV class
patients was 6–98%. Four trials gave mean and median
values of NYHA status, one trial used the all-patient
reﬁned-diagnosis related group (APR-DRG) severity of
illness scale, and ﬁve trials did not describe disease
severity.
Profile of interventions
The majority of studies (n=15) described the interven-
tion being delivered by a case manager/specialist nurse
with no speciﬁc mention of other health professionals,
and the remaining seven studies described a case
manager/specialty nurse working as part of a multidis-
ciplinary team (table 2).
All but two studies compared CM with usual care
although the control group was not always described.
The two remaining studies were comparative: one RCT
comparing CM with specialist clinics and one RCT com-
paring CM with telemedicine plus CM.32 42
The duration of the CM interventions in the studies was
1–24 months with the majority having a 3-month or
6-month duration. The majority of studies were con-
ducted face to face or a combination of in-person and by
phone. Four interventions were conducted purely by
phone.21 22 26 42 Outcomes were measured to match the
total duration of intervention in the majority of studies.
For many of the studies, the intensity of interventions was
not stated explicitly. When intensity was described, it was
always a tapered approach after an initial intensive period.
Risk of bias
The degree of risk of bias was starkly different
between the RCTs and NRCTs. All ﬁve of the NRCTs
were rated at high risk or unknown risk for most
domains (ﬁgure 2A, B).35–37 44 45
The majority of the RCTs were rated at low risk for
most domains with the exception of the domain of
blinding of the participants and personnel which is not
applicable to this type of intervention. Three RCTs were
assessed as at high risk for at least one domain: both
Hancock et al43 and Wade et al42 gave no description of
the randomisation process or allocation concealment,
Riegel et al21 was randomised at physician level and
patients were chosen by physician preference. Four of
the ﬁve community-initiated trials (two RCTs and two
NRCTs) were assessed to be at high risk of bias, and in
some studies did not present usable data.35–37 42
All the intervention studies reported unplanned hos-
pital (re)admissions14–45 and 17 reported length of time
in hospital.14 15 17 18 20–22 24 26–28 35 38 42–45 There were
few data on A and E attendance and primary care
resource use. However, only some of the data could be
used in meta-analysis with the main reasons being that
data were presented in different formats where neither
CIs, SEs nor raw data were given. Owing to heterogen-
eity of data, all analyses were conducted using a
random-effects model.
Unplanned HF (re)admissions data
Hospital-initiated CM
Thirteen of the hospital-initiated CM trials had data that
could be used in a meta-analysis of which 12 were RCTs.
The pooled data from the RCTs showed a rate ratio of
readmissions of 0.74 (95% CI 0.60 to 0.92; p=0.008;
I2=69%) in favour of hospital-initiated CM (ﬁgure 3A).
A sensitivity analysis was conducted, removing Riegel
et al21 (RCT with high risk of bias for randomisation
domain); this had a minimal effect on the rate ratio and
heterogeneity (0.77 (0.61 to 0.96); p=0.02; I2=68%).35
Subanalysis looking at 3-month, 6-month and
12–18-month data did not produce a clear time-related
effect which is most likely due to heterogeneity within
and between studies (ﬁgure 3B–D). There was one
hospital-initiated CM trial which compared CM with spe-
cialist clinics which reported no differences in hospital
readmissions between the two groups.32
Community-initiated CM
Of the four community-initiated trials (two RCTs and
two NRCTs) comparing admissions between CM with
usual care, two reported no signiﬁcant differences38 43
and two reported statistically signiﬁcant reductions in
favour of CM.44 45 One further trial compared CM, with
telehealth and CM and reported no differences in
admissions but data were not presented.42
Length of hospital stay
Hospital-initiated CM
Nine of the hospital-initiated CM trials had data that
could be used in a meta-analysis of which eight were
RCTs. The pooled data from the RCTs showed that mean
LOS was reduced in the CM group compared with usual
care mean difference (MD −1.28 days (−2.04 to −0.52);
p=0.001; I2=63%; ﬁgure 4A). A sensitivity analysis was con-
ducted removing Riegel et al21 which had an important
effect on the rate ratio and heterogeneity (MD −1.76
(−2.29 to −1.23); p<0.00001; I2=14%).21 35 Subanalysis
looking at 3-month, 6-month and 12–18-month data sug-
gests this effect is short term (ﬁrst 3 months) but a
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Table 2 Study characteristics of intervention studies
Study
n=randomised
Recruitment/setting
Baseline characteristics of
participants: CM vs usual
care Intervention Control
Main results
Intervention vs control
Hospital-initiated CM—RCTs
Rich et al,14 USA
n=98 randomised
Patients ≥70 years admitted to medical
wards of Jewish Hospital at Washington
University Medical Centre were screened
for congestive HF.
Age: 80 (6.3), 77.3 (6.1)
years p=0.04
Female (%): 60.3, 47.1%
Ethnicity: white 46, 57.1%
Disease status:
Mean NYHA status
2.7 (1.1), 3.0 (1.0)
Non-pharmacological
comprehensive multidisciplinary
treatment strategy NPCM (n=63)
Components of intervention at
home:
Monitoring signs and symptoms
Medication review (nurse)
Education/self-management
support
Assessment of home environment
Patient-directed access to study
personnel
UC (n=35)
Components of
intervention: visits by
home nurse
Number of readmissions (%)
21 (CI 21.7% to 44.9%) (33.3%),
16 (29.2% to 62.2%) (45.7%)
Total hospital days: 272, 200
Mean number of days: 4.3
(SD1.1), 5.7 (SD2.0)
Rich et al,15 USA
n=285 randomised
As above for Rich et al14
Age: 80.1 (5.9), 78.4 (6.1)
years p=0.02
Female (%): 68, 59%
Ethnicity: non-white race 52,
59%
Disease status:
Mean NYHA class
2.4 (1.0), 2.4 (1.1)
Nurse-directed multidisciplinary
intervention (n=142)
As above for Rich et al14
UC (n=140)
As above for Rich
et al14
Number of readmissions
24, 54 p=0.04
Total hospital days
556, 865
Mean number of days
3.9 (10), 6.2 (11.4)
p=0.04
Stewart et al,17 Australia
n=97 randomised
Patients were recruited while admitted to a
large tertiary hospital
Age: 76 (11), 74 (10) years
Female (%): 55, 48%
Ethnicity: non-English
speaking
20.4, 18.75%
Disease status: NYHA
II 49, 50%
III 47, 42%
III 4, 4%
Home-based intervention (n=49)
Components of intervention at
home:
Monitoring signs and symptoms
Education (pharmacist)/
self-management support
Medication review (pharmacist)
Referral to GP
Family involvement
Equipment
UC (n=48)
Components of
intervention: DM
Number of readmissions
36, 63 (p=0.03)
Number of patients experiencing
a readmission
24, 31 (p=0.12)
LOS in days
261, 452 (p=0.05)
Stewart et al,18 19 Australia
n=200 randomised
Patients admitted to a tertiary referral
hospital
Age: 75.2 (7.1), 76.1 (9.3)
Female (%): 35, 41%
Ethnicity: primary language
not English 32, 32
Disease status: NYHA
II 42, 48
III 46, 43
IV 12, 9
Multidisciplinary home base
intervention (n=100)
Components of intervention at
home:
Monitoring signs and symptoms
Referral to other health and social
care
Appointment organisation
UC (n=100)
Components of
intervention:
Contact with other
health and social
professionals
Appointment with GP
or cardiac clinic or
both
6 months
Number of readmissions
68, 188 (event rates give p=0.02)
Rate of readmissions
0.14 (0.1, 018), 0.34 (0.19, 0.49)
p=0031
LOS in days
460, 1174
0.9 (0.6, 1.2), 2.9 (1.9, 3.9)
Continued
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Table 2 Continued
Study
n=randomised
Recruitment/setting
Baseline characteristics of
participants: CM vs usual
care Intervention Control
Main results
Intervention vs control
Assessment of home environment
Family involvement
Education/self-management
support
Medication review (nurse/GP/
cardiologist)
p=0.004
18 months
Number of readmissions
64, 125, p=0.02
Mean number of hospital days
10.5 (14.4), 21.1 (24.1) days per
patient, p=0.004
Blue et al,20 UK
n=165 randomised
Patients admitted as an emergency to the
acute medical ward of the hospital
Age: (SD) 74.4 (8.6), 75.6
(7.9) years
Female (%): 36, 49%
Ethnicity: not reported
Disease status: NYHA
II 19 (23), 16 (20)
III 28 (34), 33 (42)
IV 36 (43), 30 (38)
Comorbidity or
multimorbidity:
Angina 40 (49), 38 (45)
Past MI 41 (51), 46 (55)
Diabetes 15 (19), 15 (18)
Chronic lung disease 18
(22), 23 (27)
Hypertension 42 (52), 36
(43)
AF 42 (52), 29 (35)
Valve disease 12 (15), 15
(18)
Specialist nurse intervention (n=82)
Components of intervention at
home:
Monitoring signs and symptoms
Education/self-management
support
Referral to other health and social
care
Appointment organisation
Medication review (nurse,
cardiologist )
UC (n=75)
Components of
intervention: GP care
Number(%) of readmissions
12 (14), 26 (32)
HR 0.38 (0.19, 0.76) p=0.0044
LOS in days
3.43 (12.2), 7.46 (16.6)
CI 0.6 (0.41 to 0.88), p=0.0051
Riegel et al,21 USA
n=281 physicians randomised
Patients admitted at 2 Southern California
hospitals
Age: 72.52 (13.05), 74.63
(12)
Female (%): 46.2, 53.9
Ethnicity: (primary language)
English 91 (70), 168 (73.7)
Spanish 35 (26.9), 58 (25.4)
Disease status: NYHA
II 2.3, 3.6
III 35.9, 38.4
IV 61.7, 58.0
Telephonic CM (n=130)
Components of intervention at
home:
Monitoring signs and symptoms
Self-management support
Referral to other HPs (including
GP) and social care
Family involvement
UC (n=228)
Components of
intervention: not
known
Readmission rates
3 months 14.6, 22.8 p=0.06
(calculation 19 people vs 52
experiencing 1 or more
admission)
6 months 17.7, 27.6 p=0.06
(calculation 23 people vs 63
people experiencing 1 or more
admision)
LOS in days
3 months 0.85 (2.3), 1.6 (3.9)
p=0.56
6 months 1.1 (3.1), 2.1 (4.6)
p=0.05
Continued
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Table 2 Continued
Study
n=randomised
Recruitment/setting
Baseline characteristics of
participants: CM vs usual
care Intervention Control
Main results
Intervention vs control
Laramee et al,22 USA
n=287 randomised
Patients admitted to hospital for CHF were
screened.
Age: 70.6 (11.4), 70.8 (12.2)
years
Female (%): 42, 50%
Ethnicity: not reported
Disease status (SD):
NYHA
I 10 (7), 35 (26)
II 76 (55), 47 (36)
III 50 (36), 46 (35)
IV 3 (2), 4 (3)
Note p<0.001
CM (n=131 data available )
Components of intervention at
home:
Monitoring signs and symptoms
Education/self-management
support
Family involvement
Equipment
Patient-directed access to CM
UC (n=125 data
available)
Components of
intervention: not
known
Number of readmissions
3 months period
18 (14) vs21 (17) NS
LOS in days
in hospital for those patients with
≥1 readmission
6.9 (6.5), 9.5 (9.8) NS
DeBusk et al,23 USA
n=462 randomised
Patients who were admitted with a
provisional diagnosis of HF from Kaiser
Permanente medical centres in California
Age: <60 years 15, 14%, 6–
70 years 22, 24%, 70–
80 years 40, 37%, >80 years
21, 26%
Female (%): 52, 45%
Ethnicity: American Indian 0,
1%
Asian 4, 8%
Black 2, 2%
White 5, 6%
Hispanic 3, 3%
Disease status: NHYA
I–II 50, 50%
III–IV 50, 50%
CM (n=228)
Components of intervention at
home:
Monitoring signs and symptoms
Education/self-management
support
CM meetings/feedback to other
health providers
UC (n=234)
Components of
interventions: not
known
Total number of readmissions
in 1 year
76, 86 no stats available
Naylor et al,24 25 USA
n=239 patients randomised
Patients aged 65 years+ admitted to 6
study hospitals from home with a
diagnosis of HF were screened for
participation.
Age: 76.4 (6.9), 75.6 (6.5)
Female (%): 60, 56%
Ethnicity: African-American
34, 38%, white 66, 62%
Disease status:
Functional status (Moinpur C
1992)
Personal 17.1 (5.8), 16.9
(5.8)
Social 8.4 (2.6), 8.6 (2.6)
Total 25.5 (8), 25.4 (7.8)
Transitional care intervention with
APNs (n=118)
Components of intervention at
home:
Monitoring signs and symptoms
Education/self-management
support
Family involvement
CM meetings/feedback to other
health providers
Patient-directed access to CM
UC (n=121)
Components of
intervention:
Care from standard
home care services
Patient-directed
access to home care
services
Number of readmissions
40 vears 72 NS
$175 840, $498 110
Total hospital days (all cause)
588, 970
Per patient, mean±SD 5.0±7.3
8.0±2.3 NS
Per hospitalised patient, mean
±SD
11.1±7.2 14.5±13.4 NS
Riegel et al,26 San Diego, USA
n=135 randomised
Age: 71.6910.8), 72.7 (11.2)
Female (%): 58, 49.2%
Telephonic CM (n=69)
Components of intervention at
Usual care (n=65)
Components of
Readmission rates
(%) (number of people) all NS
Continued
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Table 2 Continued
Study
n=randomised
Recruitment/setting
Baseline characteristics of
participants: CM vs usual
care Intervention Control
Main results
Intervention vs control
Self-identified Hispanics were identified at
2 community hospitals close to
US-Mexico border.
Ethnicity: Hispanic patients
Speak/read only Spanish
60.9, 65.1%
Disease Status: NYHA
II 17.4, 20%
III 44.9, 47.7%
IV 37.7, 32.3%
home:
Monitoring signs and symptoms
self-management support
Referral to other HPs (including
GP) and social care
Family involvement
intervention: DM
information
1 months 8.7, 13.8%
(Calculation 6.003, 8.97)
3-month 21.7, 26.2%
(Calculation 14.49, 17.03)
6 months 31.9, 33.8%
(Calculation 22.011, 21.97)
LOS in days
(mean) all NS
1 months 0.59 (2.3), 1.41 (5.5)
3 months 2.19 (5.4), 2.4 (6.2)
6 months 3.65 (7.8), 3.4 (7.1)
Thompson et al,27 UK
Randomisation was at GP practice level
Patients recruited from 2 North of England
general hospitals following an admission
Age: 73 (14), 72 (12)
Female (%):38, 27%
Ethnicity: no details
Disease status:
NYHA III and IV
76, 73%
Clinic and home-based intervention
(n=58)
Components of intervention at
home:
Monitoring signs and symptoms
Education/self-management
support
Family involvement
In outpatient clinic
Monitoring signs and symptoms
Education/self-management
support
Family involvement
Referral to other health and social
care
UC (n=48)
Components of
intervention at home:
unknown
Number of patients experiencing
one or more readmissions
13, 21
Total number of readmissions
15, 45
Total number of hospital days
108, 459
p<0.01 for all at 6 months
Jaarsma et al,28 29 The Netherlands
n=1049 randomised
All patients had been admitted to hospital
with symptoms of HF.
Age: 71 (11), 70 (12), 72
(11)
Female (%):34, 39, 40%
Ethnicity: no detail
Disease status: NYHA
II 51, 48, 54%
III 47, 48, 42%
IV3, 4, 4%
BNS (n=340)
Components of intervention:
Outpatients
Education/self-management
support
Patient directed access to HF nurse
INS (n=344)
Components of intervention at
home:
Patient-directed access to HF nurse
Referral to other health and social
care
Education/self-management
UC group (n=339)
Components of
intervention: DM
Number of readmissions
121,134,120 NS
LOS in days
(medians)
8.0 (4, 14), 9.5 (5, 17), 12
(5, 19.5)
p<0.01 between BNS group and
control but NS between INS
group and control
Continued
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Table 2 Continued
Study
n=randomised
Recruitment/setting
Baseline characteristics of
participants: CM vs usual
care Intervention Control
Main results
Intervention vs control
support
Equipment
Brotons et al,31 Spain
n=283 randomised
Patients were recruited by well-trained
nurses at 2 university hospitals.
Age: 76.6 (7.5), 76 (8.9)
years.
Female (%): 54.2, 56.1%
Ethnicity: not reported
Disease status: NHYA
I 42.4, 55.4%
II 52.1, 37.4%
III 4.9, 5.8%
IV 0.7, 1.4%
Home-based intervention (n=144)
Components of intervention at
home:
Monitoring signs and symptoms
Education/self-management
support
Medication review (nurse,
physician, cardiologist)
Referral to physician or cardiologist
as necessary
UC (n=139)
Components of
intervention: not
known
Number of readmissions
52, 62 NS
Mean number of readmissions
1.01, 1.3 NS
Stewart et al,32 WHICH trial, Australia
n=280 randomised
Patients admitted to participating hospitals
were screened for study eligibility.
Home vs clinic
Age: 70 (15), 73 (13) years
Female (%):27, 28%
Ethnicity: no details
Disease status: NYHA II or
III
83, 88%
Months since CHF diagnosis
34.6 (55.3), 44.8 (71.0)
Home-based intervention (n=143)
Components of intervention at
home:
Monitoring signs and symptoms
Family involvement
CM meetings/feedback to other
health providers
Referral to other health or social
care
Assessment of home environment
Medication review (nurse,
pharmacist, physician, cardiologist)
Clinic-based
intervention (n=137)
Components of
intervention:
In clinic
DM
Assessment of home
environment
Family involvement?
Referral to other
health or social care
CM meetings/
feedback to other
health providers
Rates of readmissions/100 days/
patient
0.52±0.76, 0.53±1.02 NS
Mean days of hospitalisation
4.96±8.57, 3.62±6.36 NS
At 12–18 months
Hospital-Initiated CM—NRCTs
Riegel et al,35 USA
n=240 were randomised
Patients were recruited from 5 hospitals
following a hospitalisation for HF.
Age: 74.44 years. (10.65),
70.77 (11.77)
Female (%): 55, 55%
Ethnicity: no details
Disease status: NYHA
I 19.2, 24.2%
II 26.7, 18.3%
III 43.3, 44.2%
IV 10.8, 13.3%
Multidisciplinary DM (n=120)
Components of intervention at
home:
Monitoring signs and symptoms
Support group
Referral to specialist RN visits
UC (n=120)
Components of
intervention at home:
DM
Readmission rates
3 months
0.22 (0.52), 0.13 (0.45) (NS)
6 months
0.32 (0.58), 0.23 (0.53) (NS)
LOS in days
3 months
0.89 (3.34), 0.48 (1.64) (NS)
6 months
1.31 (3.77), 1.08 (3.46) (NS)
Russell et al,36 USA
n=447
Age: 79.4 (10.7), 79.9 (10.7)
Female (%): 55.6, 57.6
(numbers)
Transitional care service (n=223)
Components of intervention at
home:
Usual home care
services (n=224)
Components of
Readmissions
Unadjusted OR 30 days
0.58 (0.38, 0.88) p<0.01
Continued
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Table 2 Continued
Study
n=randomised
Recruitment/setting
Baseline characteristics of
participants: CM vs usual
care Intervention Control
Main results
Intervention vs control
Patients were referred from a single large
not-for-profit general medical and surgical
hospital.
Ethnicity:
White non-Hispanic 56.9,
58.4
African-American 17.0, 16.5
Hispanic 14.8, 14.
Asian/other 11.2, 10.7
Disease status: patients with
a primary or secondary
diagnosis of CHF
Self-management support
Referral to other health and social
care
Assessment of home environment
CM meetings/feedback to other
health providers
Advance care planning
Physical therapy
intervention at home:
Nurse visits
Physical therapy
(44.6)
Home health aide
service (27.7)
Adjusted OR 30 days
0.57 (0.38, 0.87) p<0.01
Stauffer et al,37 USA
n=140
Patients were screened for eligibility within
48 h of hospital admission
Age: 78.9 (8.3), 81.4 (8.3)
Female (%): 58.1, 54.8%
Ethnicity: Hispanic ethnicity
7.1, 3.6%
Disease status:
APR-DRG severity of illness
1 5.4, 1.2%
2 44.6, 31%
3 37.5, 57.1%
4 12.5, 10.7%
Nurse-led transitional care
intervention (n=56)
Components of intervention at
home:
Monitoring signs and symptoms
Education/self-management
support
Family involvement
Referral (assessing availability of
social care)
Patient-directed access to study
personnel
Control group (n=84)
Components of
interventions:
unknown
Readmission rate at 30 days
12.6 (7.4, 17.8) difference −12.6,
per cent change −48%; 16.4 (14,
18.7) difference −1.6% change
11%
Community-initiated CM—RCTs
Peters-Klimm et al,39 Germany
n=199 at randomisation
Recruitment was via general practice by
mail.
Baseline characteristics of
participants: CM, UC
Age: 70.4 years (10.0), 68.9
(9.7)
Female (%):29, 26%
Ethnicity: no details
Disease status: NYHA
I 1 (1.0), 5 (5)
II 63 (64.9), 67 (67)
III 33 (34), 27 (27)
IV 0, 1 (1.0)
Mean years with CHD
6.2 (4.6) (n=79), 6.8 (6.3)
(n=74)
CM (n=97)
Components of intervention at
home:
Monitoring signs and symptoms
Education/self-management
support
Medication review (CM/GP)
Referral to GP
UC (n=100)
Components of
control intervention:
DM
Education
Number of admissions
(baseline 36 vs 35)
18 vs 9 at 12 months (NS)
Number of patients experiencing
one or more CHF admissions
11 vs 7 at 12 months (NS)
Wade et al,42 USA
n=2200 were randomised
Age: 75.8, 77.7 years.
Female (%): no detail
CM (n=152)
Components of intervention at
home:
THCM (n=164)
Components of
intervention:
No data available for primary
outcome but described as NS
Continued
Huntley
AL,etal.BM
J
Open
2016;6:e010933.doi:10.1136/bm
jopen-2015-010933
11
O
p
e
n
A
c
c
e
s
s
group.bmj.com
 o
n
 M
ay 12, 2016 - Published by 
http://bmjopen.bmj.com/
D
ow
nloaded from
 
Table 2 Continued
Study
n=randomised
Recruitment/setting
Baseline characteristics of
participants: CM vs usual
care Intervention Control
Main results
Intervention vs control
Aetna Medicare Advantage members with
medical and pharmacy benefits were
identified through analysis of claims.
Ethnicity: black/
African-American
24, 20.4%
Disease status (SD): no
detail
Referral to other health and social
care
Equipment
DM
Education
Referral to other
health and social
care
The participant population overall
had 42% fewer inpatient days
during the intervention period
compared with the previous year.
No data
Hancock et al,43 UK
n=28 randomised
Residents from 33 of 35 long-term
residential and nursing homes
Age: 85.1 (6.7), 81.8 (7.1)
years
Female (%):56%, 58%
Ethnicity:100% white British
Disease status:
I:II:III:IV
10:1:4:1, 5:4:1:1
CM (n=16)
Components of interventions at
home:
Monitoring signs and symptoms
Education
CM meetings/feedback to other
health providers
Medication review (CM/GP/
cardiologist )
Routine GP-led care
(n=12)
Components of
intervention: DM
Number of admissions
at 6 and 12 months
0, 0 at 6 months
0, 0 at 12 months
Community-initiated CM—NRCTs
Bonarek-Hessamfar et al,44 France
n=362
Compared patients included prospectively
from 1 January 2004 to 31 December
2005 from GP list
Age: median 78, 80 years.
Female (%): no details
Ethnicity: no details
Disease status: NHYA
Median of III, IV
Coordinated care via
multidisciplinary network (n=129)
Components of intervention at
home:
Monitoring signs and symptoms
Education (diet)
Physical therapy
CM meetings/feedback to other
health provider
UC ( n=233)
Components of
intervention: not
known
Number of patients experiencing
at least one admission
26, 58
Total number of admissions
35, 96
Median LOS
9.2, 11.7 days
In the 2-year period
Lowery et al,45 USA
n=1043
Intervention implemented in 4 Midwest VA
medical centres from the same region and
one affiliated outpatient clinic and 2 VA
medical centres served as control.
Age: 65.4 (0.51), 67.4 (0.45)
years.
Female (%):1, 1%
Ethnicity:
White 71.2, 79.9%
Black 24, 16.1%
Other 4.8, 4.0%
Disease status: no details
Nurse-practitioner-led DM model
(n=457)
Components of intervention at
home:
Location was lead tertiary centre,
other medical centres (some
primary care) or one affiliated
outpatient clinic.
Monitoring signs and symptoms
Education/self-management
support
Referral to other health and social
care
Family involvement
UC (n=510)
Components of
intervention: not
known
Mean number of readmissions
1 year
0.7 (0.32), 0.23 (0.65) p<0.001
(417, 428)
2-year
0.15 (0.58), 0.13 (0.42) NS
(384, 382)
Mean number of days in hospital
1 year
0.37 (2.25), 0.97 (3.15) p=0.0014
2-year
0.86 (3.98), 0.66 (2.74) NS
AF, atrial fibrillation; APN, advanced practice nurse; APR-DRG, all-patient refined-diagnosis related group; BNS, basic nurse support; CHD, coronary heart disease; CHF, chronic heart failure;
CM, case management or case manager; COPD, chronic obstructive pulmonary disease; DM, disease management; GP, general practitioner; HOCM/RCM, hypertrophic obstructive/restrictive
cardiomyopathy; HP, health professional; INS, intensive nurse support; LOS, length of hospital stay; LV, left ventricular; MI, myocardial infarction; NPCM, non-pharmacological comprehensive
multi-disciplinary treatment strategy; NRCT, non-randomised controlled trial; NS, not statistically significant; NYHA, New York Heart Association; PAD, peripheral arterial disease; SNF, skilled
nursing facility; THCM, telehealth with CM; UC, usual care.
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longer time-related effect was difﬁcult to assess due to
lack of data (ﬁgure 4B–D).
The one study comparing CM with specialist clinic
care reported that CM patients accumulated 592 and
clinic patients 547 all-cause hospitalisations (p=0.087)
associated with 3067 vs 4410 days of hospital stay (p<0.01
for rate and duration of hospital stay).32
Community-initiated CM
Of the four community-initiated trials comparing CM
with usual care, two did not report LOS,38 43 one
reported median values in favour of CM44 and the
remaining one reported a mean reduction in LOS45
(table 2). The one comparative trial between
community-initiated CM, and telehealth and CM did
not report any useful data.42
Intervention components
Fourteen intervention components were identiﬁed and
grouped as per the CM deﬁnition in methods and preva-
lence determined for hospital-initiated and
community-initiated CM studies with a usual care
control group (see tables 1 and 2 and online
supplementary appendix 2).7
Figure 2 (A) Risk of bias of included randomised controlled trials. (B) Effective Practice and Organisation of Care (EPOC) risk
of bias for non-randomised controlled trials.
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Figure 3 Chronic heart failure (CHF) admissions data. CM, case management.
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Hospital-initiated CM
Data from individual studies which contained compo-
nents of family involvement showed an overall reduction
in hospital readmissions in comparison with usual care
and a reduction in hospital readmissions observationally
in comparison with interventions which did not contain
these components (rate ratio of 0.56 (0.34 to 0.92);
p=0.003). However, post hoc analysis comparing these
studies, in which the component was present with those
studies in which the component was absent, did not yield
any statistically signiﬁcant differences (p=0.15; see online
supplementary appendix 2a). The same calculations for
medication review; referral to other services; and assess-
ment of home environment, CM meetings and patient-
directed access did not indicate any speciﬁc effect of
these components of hospital-initiated CM on rates of
admission (see online supplementary appendix 2b–g)
The majority of the interventions included education/
self-management, and there were insufﬁcient data from
studies without this component to allow comparison.
Community-initiated CM
There were insufﬁcient data to conduct any subgroup ana-
lysis on any of the remaining components of hospital-
initiated CM, community-initiated studies or the LOS data.
Outpatient healthcare resources
Only six of the included studies measured outpatient
resource use. In some studies, outpatient resource data
were all-cause and not HF-speciﬁc. In some studies, primary
and secondary use was combined.23 24 35 38 42 45 Two of
these studies also reported ED attendance.23 42 All but one
of these studies reported no difference between interven-
tion and control group for these measures with the
Figure 4 Chronic heart failure (CHF) length of hospital stay. CM, case management.
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exception of Lowery et al45 which showed a statistically sig-
niﬁcant greater use of outpatient resources in the usual
care group (optional primary care visits 1 year 16.75
(13.62); 10.43 (9.6), p<0.001; 2 year 14.27 (11.98); 9.35
(9.97), p<0.001).
Costs
Nine of the 17 hospital-initiated trials described cost data
(table 3). Of these, six reported no statistically signiﬁcant
difference between CM (3-month or 6-month duration)
and usual care,17 18 22 24 26 35 and three reported costs in
favour of CM although data from Stauffer et al37 was
brief.15 32 One of these was 12–18 months32 and two were
3 months in duration. It was difﬁcult from the interven-
tion descriptions to determine their intensity. There were
no cost data reported from the community-initiated trials.
DISCUSSION
This systematic review conﬁrms that hospital-initiated CM
can be successful in reducing unplanned hospital
Table 3 Available cost data from studies (n=9)
Study Cost data intervention vs control (NS=not statistically significant)
Rich et al15 3-month data
Study intervention cost US$216 per person
Hospital readmissions $2178 vs $3236 p=0.03
Stewart et al17 6-month data
Cost of study intervention $A$190 per person
Mean cost of hospital-based care
$3200 (1800–4600), $5400 (3200–6800) NS
Cost of community-based care
$620 (460 740), $680 (550 800) NS
Stewart et al19 6-month and 18-month data
6 months
Total hospital-based care $A$490 300 vs $A922 600 NS
18-month data
Total hospital-based care $5100 (6800) vs $10 600 (13 000) NS
Laramee et al22 3-month data
Total care costs
Mean(US$) 23 054 vs25 536 NS
Naylor et al24 12-month data
CHF readmissions US$175 840 vs US$498 110?
Physician’s office (outpatients)$4549, $5169 NS
ER visits $1780 vs $5650 NS
Home visits (all cause)
Visiting nurse $11 021, $64 531 p<0.001
APN $104 019 vs 0
Physical therapist $7120 vs $10 918 NS
Social worker $178 vs $534 NS
Home health aides $9167 vs $11 081 NS
Total home visits $138 649 vs $97.883 p<0.001
Total costs $725 903, $1 163 810 NS
Stewart et al32 12–18-month data
Costs per patient
$A$1813 (220) vs A$1829 (174) NS
Total costs
$A$3.93 million vs A$5.53 million p=0.03 for median costs per day
Riegel et al35 3-month and 6-month data
Total costs
3 months US$632 (2378) vs US$317 (1188) NS
6 months $1024 (3017) vs $686 (2225) NS
Riegel et al36 1-month, 3-month and 6-month data
HF inpatient costs all NS
1 month US$1012 (4022) vs US$2830 (13 896)
3-month $3045 (7784) vs $4130 (14 468)
6-month $5567 (13 137) vs $6151 (16 650)
Stauffer et al37 1-month data
‘Under the current payment system, the intervention reduced the hospital financial contribution on
average by US$227for each Medicare patient with HF’
APN, advanced practice nurse; CHF, chronic heart failure; ER, emergency room.
16 Huntley AL, et al. BMJ Open 2016;6:e010933. doi:10.1136/bmjopen-2015-010933
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readmissions, and reducing LOS in hospital in the short
term for people with HF. There were only ﬁve community-
initiated CM studies (three RCTs and two NRCTs) of
which four were at high risk of bias. This limited evidence
suggests no effect of community-initiated CM on hospital
admissions. A minority of trials report cost comparisons
with usual care and most of those show no difference.
There were limited data on the effect of CM on other
healthcare resources.
Many factors are likely to modify the effect of CM on
use of emergency care seen in these studies. It is gener-
ally accepted that CM is more appropriate for people
with severe HF and poorer general health. However, it
was difﬁcult to compare the health status of the study
participants in hospital-initiated and community-initiated
trials as in some studies there was little detail, others
gave median and mean ﬁgures for NYHA status, and the
presentation format and detail of comorbidities varied.
All the included studies have been conducted within the
past 12 years, so it is important to put these results in
the context of overall improved treatment and reduction
in hospital admissions since the early 1990s.4–6
Seventeen studies described hospital-initiated CM and
ﬁve described community-initiated CM of HF, although
often the participants were identiﬁed via hospital clinic
records. Overall, the meta-analysis showed that CM
reduced readmissions and hospital LOS. This may be
explained by the fact that in most of the trials the parti-
cipants were identiﬁed via hospital contact, and there-
fore were likely to have had a recent exacerbation of
their HF and to be at increased risk of readmission in
the postdischarge period. In addition, it is likely that
interventions are acting at a time of highest risk as
reﬂected by HF mortality in ﬁrst year of diagnosis.4
Therefore, once they were assessed and given extra
support, they were stable for a period of time. Previous
work by Roland et al46 suggests that admission rates in
people aged 65 with two or more emergency admissions
in 12 months fall in subsequent years without any inter-
vention and account for fewer than 10% of admissions
in the following year, and thus effectiveness of admission
avoidance schemes cannot be judged by tracking admis-
sion rates without careful comparison with a control
group. The data from trials of community-initiated CM
was lacking both in the number of studies, and the fact
there were limited useable data that showed no effect on
unplanned hospital admissions. It is likely that these
patients were likely to be in more stable health.41
A metareview of a wide range of HF disease manage-
ment programmes by Savard et al47 reports that nine
previous systematic reviews (2001–2009) identiﬁed sig-
niﬁcant reductions in HF admissions with reductions in
risk ranging from 30% to 56%. However, the authors
caution that these reviews are limited by inadequate
reporting in the population, setting, intervention and
comparator components. They report that reviewers
have not taken into account statistical, clinical and meth-
odological heterogeneity in interventions.47 Our review
focused speciﬁcally on CM avoiding some of these lim-
itations and indicates a reduction in HF readmissions
with hospital-initiated CM in the range of 10–30%.
Wakeﬁeld et al48 in 2013 looked at common compo-
nents of a range of HF care programmes focusing
mainly on disease management and education investi-
gated in RCTs, and 10/35 of the discussed studies were
included in our review. They described patient educa-
tion, symptom management by health professionals and
by patients, and medication adherence strategies as the
most commonly occurring elements of care. A literature
review by Jaarsma et al49 looked at 70 ‘home care’ con-
trolled studies (mostly RCTs) which encompassed 9 of
our included CM studies covering a wide range of
approaches such as telemedicine, hospital at home and
health buddies for patients with HF. They identiﬁed a
multidisciplinary team, continuity of care, care plans,
optimising titration of medication, education/counsel-
ling of patients and caregivers and increased access as
important. Unfortunately, we had insufﬁcient data to
perform subanalysis on the component of education/
self-management.
Previous systematic reviews have investigated the role
of the lay caregiver in HF patient management.50–52
These suggest that better relationship quality and com-
munication were related to reduced mortality, increased
health status and less distress, and improved patient self-
care outcomes. Our review adds to this evidence base by
suggesting that more family involvement in CM may also
reduce unscheduled readmissions.
Education about HF and about its pharmacological
and non-pharmaceutical treatment has been well
reviewed both as an individual approach and as part of
complex interventions, and is considered to be essential
for improving many patient outcomes.49 53 54 A recent
mixed-method study suggests asking patients with HF to
write down their learning needs before the education
increases their chances of receiving education based on
their individual needs.55 Qualitative interviews with
health professionals caring for patients with HF suggest
that communication with, and education by specialist
nurses facilitated by continuity of care is essential to good
care of patients with HF. The authors also highlight the
role of the specialist nurse in multidisciplinary team com-
munication and functioning, essentially describing the
role of the specialist nurse as a case manager.56
Our review of CM suggests that the evidence for its
cost-effectiveness is lacking with most studies that have
performed cost comparisons with usual care show no
advantage. Previous work by de Bruin et al 57 looked at
cost-effectiveness of disease management for a range of
chronic conditions and concluded that the data are
most positive for HF with ﬁve out of the eight included
studies showing cost-effectiveness.
Strengths and limitations
The contribution of our high-quality systematic review to
the above is that we have focused on CM which is based
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on nurse coordinated multicomponent care of patients
which is applicable to the primary care-based health
systems such as that in the UK. We have focused on HF
(re)admissions and LOS as opposed to all-cause data
which many of the previous reviews have used.
By examining the components of CM, we have a
proﬁle of the components most likely to lead to the
success of CM of patients with HF in terms of reducing
(re)admissions and hospital LOS. Our review has high-
lighted the potential importance of family involvement
albeit in post hoc analysis.
The limitations of this review are that majority of the
community-initiated CM studies were of low quality with
the exception of one low risk of bias RCT, and provided
limited evidence. While funnel plot analysis was not
appropriate with our data, we acknowledge that there
may be publication bias on this topic.58 This was coun-
teracted by the fact that the hospital-initiated studies
comprised of predominantly community-based CM.
There is a lack of cost data and analysis in the
included papers. This point needs to be emphasised
for future trials. It is possible that cost-effectiveness
will be more likely with intervention for patients with
more severe HF.
CONCLUSIONS
Hospital-initiated CM reduces unplanned hospital
admissions, and LOS for people with HF in the short
term. Cost data are limited. There was limited evidence
for community-initiated CM which suggested it does not
reduce hospital admission. Further research is needed
to determine the individual components of CM that
contribute to reduced admissions.
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